Enters into Cooperation Agreement with Browning WestSAN RAMON, Calif., Dec. 23, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading medical device company, announced today that the Company’s Board of Directors (the “Board”) has appointed Walter (Walt) M Rosebrough, Jr. as an independent director, effective as of January 3, 2026. In connection with this appointment, the Company also has entered into a cooperation agreement (the “Cooperation Agreement”) with Browning West, LP. (“Browning West”). ...

Core Viewpoint - Inspirato Incorporated has reaffirmed its independent strategy in light of unsolicited acquisition interest, determining that pursuing such a transaction is not in the best interests of the company and its stakeholders [1][2] Group 1: Company Strategy and Vision - The company has executed a focused transformation over the past 14 months, emphasizing a commitment to maximizing long-term shareholder value [2] - Inspirato is stronger than ever, with a resilient business model and a clear vision for the future, while remaining open to strategic opportunities that align with its mission [2][3] - The company is positioned for a strong future characterized by enhanced member offerings, profitable growth, and a commitment to transparency and long-term value creation [3] Group 2: Financial Performance and Initiatives - Inspirato has achieved trailing 12-month EBITDA profitability as of Q2 2025, indicating improved financial health [7] - The company has reduced overhead by tens of millions, creating a leaner and more agile business [7] - Inspirato has relaunched the Inspirato Pass, expanding access and delivering more value to its members [7]